Janux Therapeutics - Immunotherapies for Cancer
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Platform
    • TRACTr Program
  • Pipeline
    • Drug Programs
    • Research Programs
  • Careers
  • News
  • Contact
page headd=er

News

  • All
  • 2021
  • 2020
December 21, 2020
Janux CEO to Present at H.C. Wainwright Virtual BIOCONNECT 2021 Virtual Conference
December 17, 2020
Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T-Cell Engager (TRACTr) Technology

HOME | ABOUT | TECHNOLOGY | PIPELINE | CAREERS | CONTACT

Copyright ©2021 Janux Therapeutics | Terms of Use

logo
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Platform
    • TRACTr Program
  • Pipeline
    • Drug Programs
    • Research Programs
  • Careers
  • News
  • Contact